Dr. Mark J. Ellenbogen, MD

  • Needham, MA
  • Pulmonologist
NPI1902831001PAC ID9436182706
Medicare services, 2024
605
Medicare patients, 2024
285
Part D claims, 2024
2,778
Hospital affiliations
6
Industry payments
$121
Practice address
148 Chestnut St, Needham, MA 02492
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD

Acute Care Hospital outpatient department · Needham, Massachusetts

See all 12 affiliations

Find Dr. Ellenbogen's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark J. Ellenbogen is a pulmonologist in Needham, Massachusetts

Dr. Ellenbogen practices at The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts.

Dr. Ellenbogen's NPI, 1902831001, was assigned on July 11, 2006. Dr. Ellenbogen graduated from Albert Einstein College of Medicine of Yeshiva University in 1970. Dr. Ellenbogen holds Massachusetts license 36631.

NPI and contact details
Medicare PAC ID
9436182706
NPI enumeration date
July 11, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
82
Medical school graduation
1970

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark J. Ellenbogen practices at The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts

Dr. Ellenbogen's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD, at 148 Chestnut St, Needham, MA 02492.

  • The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD
    148 Chestnut St, Needham, MA 02492

Source: Dmand AI Affiliation Data

Dr. Mark J. Ellenbogen is affiliated with 11 sites of care and 1 medical group

Dr. Ellenbogen's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts. Dr. Ellenbogen is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Beth Israel Deaconess Healthcare. Dmand AI also links Dr. Ellenbogen to 5 more hospitals, 3 home health agencies and 1 group practice or clinic, each named with a free account.

See all 12 affiliations for Dr. Ellenbogen

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Mark J. Ellenbogen's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ellenbogen practices, 11 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPDAvailable with a free account
+10 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Ellenbogen practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark J. Ellenbogen is one of 485 pulmonologists in Massachusetts

Pulmonary disease is Dr. Ellenbogen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Ellenbogen is licensed in Massachusetts.

Specialties and state licenses

  • Pulmonary disease, MassachusettsPrimaryLicense 36631 · taxonomy 207RP1001X

Pulmonologists near Dr. Ellenbogen

Counts of pulmonologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark J. Ellenbogen billed Medicare for 605 services in 2024

CMS data shows 605 Medicare services from Dr. Ellenbogen across 4 procedure codes in 2024, for 285 Medicare patients. Medicare paid $39,821 for them. Every service was in an office.

Medicare services, 2024605
Medicare patients285
Paid by Medicare$39,821
Procedure codes4

Dr. Ellenbogen's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6482024: 6057%

Dr. Ellenbogen compared with the Massachusetts median for pulmonologists, 2024

  • Dr. Ellenbogen
  • Massachusetts median
Medicare services
605vs 47527% above
Medicare patients
285vs 25512% above
Part D claims
2,268vs 3296.9 times

Medians across 481 pulmonologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Ellenbogen's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Ellenbogen

Need commercial claims for Dr. Ellenbogen?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ellenbogen and other pulmonologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark J. Ellenbogen treated 285 Medicare patients in 2024, average age 77

CMS counts 285 Medicare patients who saw Dr. Ellenbogen in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ellenbogen's median patient age at 73, with 40% women.

Medicare patients, 2024285
Average age77
Average risk score1.11
Also on Medicaid5%

Dr. Ellenbogen's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Ellenbogen's Medicare patients by sex, 2024

  • Women11440%
  • Men17160%

Chronic conditions among Dr. Ellenbogen's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure68%
  3. Arthritis53%
  4. Ischemic heart disease31%
  5. Osteoporosis24%
  6. Cancer21%
  7. Atrial fibrillation20%
  8. Chronic kidney disease20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Ellenbogen's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women40%
  • Men60%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark J. Ellenbogen wrote 2,778 Medicare Part D claims in 2024

In 2024, Dr. Ellenbogen wrote 2,778 Medicare Part D claims for 330 patients. 89% of them were for generic drugs. CMS names the drug for 2,268 of them, across 59 drugs with 11 or more claims each, at $103,676 in total drug cost. In 2023, CMS named 1,986 claims across 53 drugs.

Part D claims, 20242,778
Drugs named by CMS59
Total drug cost$103,676
Part D patients330

Dr. Ellenbogen's Part D claims by kind of drug, 2024

  • Generic2,483 claims89%
  • Brand-name and other295 claims11%

Dr. Ellenbogen's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Ellenbogen's Part D claims, 2024

  • Opioids3%77 of 2,778 claims
  • Antibiotics3%88 of 2,778 claims
  • Antipsychotics, patients 65 and over1%16 of 2,778 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,9862024: 2,26814%

Drugs named by CMS: 59 in 2024, 53 in 2023.

See all prescribing by Dr. Ellenbogen

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark J. Ellenbogen offers telehealth to Medicare patients

Dr. Ellenbogen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ellenbogen as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find pulmonologists like Dr. Ellenbogen by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark J. Ellenbogen received $121 in industry payments in 2023

CMS Open Payments shows 1 general payment to Dr. Ellenbogen from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $121.

Companies that paid Dr. Ellenbogen the most, 2023 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Ellenbogen

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark J. Ellenbogen graduated from Albert Einstein College of Medicine of Yeshiva University

Dr. Ellenbogen graduated from Albert Einstein College of Medicine of Yeshiva University in 1970.

  1. Medical schoolAlbert Einstein College of Medicine of Yeshiva University

Source: Dmand AI Professional Profile Data

Sources for Dr. Mark J. Ellenbogen's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark J. Ellenbogen

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark J. Ellenbogen's NPI number?

Dr. Mark J. Ellenbogen's NPI number is 1902831001. It was assigned on July 11, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark J. Ellenbogen?

Dr. Mark J. Ellenbogen is a pulmonologist in Needham, Massachusetts. The primary specialty in the NPI Registry is Pulmonary Disease Physician (taxonomy code 207RP1001X).

Where does Dr. Mark J. Ellenbogen practice?

Dr. Ellenbogen practices at 148 Chestnut St, Needham, MA 02492. Dr. Ellenbogen's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts. Dmand AI also links Dr. Ellenbogen to 5 hospitals, 3 home health agencies and 1 group practice or clinic.

What is Dr. Mark J. Ellenbogen's medical license number?

Dr. Ellenbogen holds Massachusetts license 36631.

Which hospitals is Dr. Mark J. Ellenbogen affiliated with?

Dr. Ellenbogen is affiliated with Beth Israel Deaconess Hospital-Needham. Dmand AI links Dr. Ellenbogen to 5 more hospitals.

What medical group is Dr. Mark J. Ellenbogen part of?

Dr. Ellenbogen is linked to Beth Israel Deaconess Healthcare.

Does Dr. Mark J. Ellenbogen accept Medicare?

Yes. CMS data shows Dr. Ellenbogen billed Medicare for 605 services in 2024, and Dr. Ellenbogen accepts Medicare assignment.

Does Dr. Mark J. Ellenbogen offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Ellenbogen as offering telehealth services.

How many Medicare patients does Dr. Mark J. Ellenbogen see?

CMS counts 285 Medicare patients who saw Dr. Ellenbogen in 2024, with an average age of 77.

What services does Dr. Mark J. Ellenbogen bill to Medicare?

In 2024, Dr. Ellenbogen's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and care management and other visits (99443).

Show 4 more questionsShow fewer questions

Where did Dr. Mark J. Ellenbogen go to medical school?

Dr. Ellenbogen graduated from Albert Einstein College of Medicine of Yeshiva University in 1970.

What drugs does Dr. Mark J. Ellenbogen prescribe most?

In 2024 Medicare Part D data, Dr. Ellenbogen's most prescribed drugs by claims were Atorvastatin Calcium, Rosuvastatin Calcium and Amlodipine Besylate.

Has Dr. Mark J. Ellenbogen received payments from drug or device companies?

CMS Open Payments shows $121 in general payments to Dr. Ellenbogen from 1 company from 2023 to 2023. The largest total came from GlaxoSmithKline, LLC.

How long has Dr. Mark J. Ellenbogen been practicing?

Dr. Ellenbogen graduated from medical school in 1970, 56 years ago.

Selling to pulmonary disease practices?

See pulmonologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)